ArticleJournal for immunotherapy of cancer2022

Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19

Christopher A Pennell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.